Source: International Congress 2014 – Biology and pathology of thoracic tumours
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Akita, N. Hattori, K. Fujitaka, Y. Haruta, H. Murai, N. Kohno (Hiroshima, Japan). Antitumor effect of a humanized antibody against aminopeptidase N in mouse tumor models.. Eur Respir J 2014; 44: Suppl. 58, 2700

Member's Comments

No comment yet.

Related content which might interest you: Cetuximab administered through pulmonary route in a mice model of lung tumor Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 Chemopreventive effect of phosphodieasterase-4 inhibition in benzo(a)pyrene-induced murine lung cancer model Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Mouse lung adenocarcinoma cell lines reveal Prl2c2 as a novel lung tumor promoter Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 Promotion of lung cancer progression by COPD-like chronic inflammation in a mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 NRAS mutations destine tumor cells to the lungs Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 Comprehensive evaluation of nuclear factor-κΒ expression patterns in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 cAMP-response element binding protein in KRAS-driven lung adenocarcinoma Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 CK2 enzyme affinity against c-myc424-434 substrate in human lung cancer tissue Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Polymorphism of HLA-G gene promotor in patients with non small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Gene expression of EGFR, MINA53,MEN1 and MTOR in NSCLCs Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 The value of miR221 and miR222 as a biomarker in non small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 LATE-BREAKING ABSTRACT: Osteopontin as an airway epithelial tumor promoter Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Functional impairment of NK cells in non-small-cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Expression of interleukin-27 (IL-27) in mixed mononuclear-tumor cells culture Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Antitumor efficacy of the double suicide genesin lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Integrative analysis of DNA copy number in metastatic NSCLC identifies drug sensitivity to Afatinib Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013